Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Lupus / September 2004

Tip: Looking for answers? Try searching our database.

Re Neuro

Thread view: 
Enable EMail Alerts  Start New Thread
Thread rating: 
Lassy Lass - 27 Sep 2004 19:34 GMT
My reg doc, has reffered me to UC Davis in Sac, I am on a waiting list
to be seen there.  I am not sure how long the waiting list is but to me
it will be worth it.  With the keppra, I do want off it very much so.
Hopefully the neuro in Sac will be a nice one.  ((((((((hugs to
everyone)))))))Melody
J - 28 Sep 2004 13:57 GMT
> My reg doc, has reffered me to UC Davis in Sac, I am on a waiting list
> to be seen there.  I am not sure how long the waiting list is but to me
> it will be worth it.  With the keppra, I do want off it very much so.
> Hopefully the neuro in Sac will be a nice one.  ((((((((hugs to
> everyone)))))))Melody

Hugs Melody,,
Perhaps when you see the next one, if he asks "how many sezures", tell him
of the known events, then explain the "fugue-like" events that you've
unsure of.

You take care now and please have someone review your meds soon.
Take that list that you posted, copy it into a  word processing, type the
alternate name for the med, why and when it was prescribed and hopefully
someone can look at the big picture (or medications). There may be some
tweaking or changes  that they may want to make.
hugs now, Melody
J
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread
Enable EMail Alerts
Rate this Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.